{"id":"W4377690919","doi":"10.1016/j.jaad.2023.05.033","title":"Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Calgary Laboratory Services; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Dupilumab; Atopic dermatitis; Randomized controlled trial; Open label; Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003220596,0.000730558,0.00154899,0.000278158,0.0004143811,0.001054831,0.0006600482,0.0009084113,0.003413884],"category_scores_gemma":[0.002869129,0.0003258314,0.00218827,0.0003274966,0.0009567286,0.000887684,0.000325691,0.002265285,0.0003197762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007502939,"about_ca_system_score_gemma":0.001025032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006533786,"about_ca_topic_score_gemma":0.001703103,"domain_scores_codex":[0.9983218,0.0008985144,0.0001698915,0.0002136896,0.0001870358,0.0002089155],"domain_scores_gemma":[0.9973902,0.0008727502,0.0007707056,0.0002148136,0.0001881764,0.0005633727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9452788,0.00999453,0.003975352,0.0005482016,0.001385022,0.00003976946,0.00008092045,0.0002933761,0.00370004,0.00005317461,0.0004579951,0.03419275],"study_design_scores_gemma":[0.7144188,0.25321,0.02380606,0.0000996058,0.002550842,0.0001648726,0.00009372496,0.000941941,0.003479623,0.0002182823,0.0009755195,0.00004076796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951943,0.002323558,0.0002138353,0.0001335378,0.0001025572,0.0008686307,0.0004456381,0.00002319727,0.0006948986],"genre_scores_gemma":[0.9969477,0.0008339856,0.000426729,0.0002114023,0.0001567339,0.0005301717,0.0005054711,0.000005817415,0.0003819868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003413884,"threshold_uncertainty_score":0.01703238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0364510700267382,"score_gpt":0.3680601446707623,"score_spread":0.3316090746440241,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}